SW
VRTX icon

SteelPeak Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

SteelPeak Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Buy
656
+54
+9% +$23.9K 0.01% 507
2026
Q1 		$269K Buy
+602
New +$281K 0.01% 481
2025
Q3 		– Sell
-22,594
Closed -$10.1M – 673
2025
Q2 		$10.1M Buy
+22,594
New +$10.4M 0.39% 66
2024
Q4 		– Sell
-20,163
Closed -$9.38M – 638
2024
Q3 		$9.38M Buy
20,163
+19,604
+3,507% +$9.42M 0.41% 56
2024
Q2 		$262K Sell
559
-20,936
-97% -$9.09M 0.01% 411
2024
Q1 		$8.99M Buy
21,495
+1,436
+7% +$607K 0.45% 53
2023
Q4 		$8.16M Buy
20,059
+19,456
+3,227% +$7.19M 0.47% 58
2023
Q3 		$210K Sell
603
-545
-47% -$191K 0.01% 375
2023
Q2 		$404K Sell
1,148
-111
-9% -$37.4K 0.02% 275
2023
Q1 		$397K Sell
1,259
-12,963
-91% -$3.89M 0.03% 267
2022
Q4 		$4.11M Buy
14,222
+13,422
+1,678% +$4.09M 0.3% 72
2022
Q3 		$232K Buy
+800
New +$230K 0.02% 355
2021
Q3 		– Sell
-3,734
Closed -$753K – 481
2021
Q2 		$753K Buy
3,734
+2,516
+207% +$526K 0.05% 208
2021
Q1 		$262K Sell
1,218
-8,310
-87% -$1.83M 0.02% 319
2020
Q4 		$2.25M Sell
9,528
-6,849
-42% -$1.57M 0.2% 94
2020
Q3 		$4.46M Buy
16,377
+1,126
+7% +$311K 0.48% 56
2020
Q2 		$4.43M Buy
+15,251
New +$4.13M 0.56% 52

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

SteelPeak Wealth's VRTX Position: Q2 2026 in Review

SteelPeak Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 9% in Q2 2026, buying an estimated $23.9K and bringing the position to 656 shares worth $326K. The position accounts for 0.01% of the portfolio, ranked #507.

SteelPeak Wealth first reported a position in VRTX in Q2 2020 and has held it in 17 quarters since. The position peaked at $10.1M in Q2 2025. 484 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • SteelPeak Wealth held 656 shares of Vertex Pharmaceuticals worth $326K as of Q2 2026.
  • SteelPeak Wealth bought 54 Vertex Pharmaceuticals shares in Q2 2026, an estimated $23.9K.
  • Vertex Pharmaceuticals made up 0.01% of SteelPeak Wealth's portfolio in Q2 2026, its #507 holding.
  • SteelPeak Wealth first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 17 quarters since.
  • SteelPeak Wealth's Vertex Pharmaceuticals position peaked at $10.1M in Q2 2025.
  • 484 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.